var data={"title":"Clinical manifestations and diagnosis of blastomycosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Clinical manifestations and diagnosis of blastomycosis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/contributors\" class=\"contributor contributor_credentials\">Robert W Bradsher, Jr, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/contributors\" class=\"contributor contributor_credentials\">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/contributors\" class=\"contributor contributor_credentials\">Jennifer Mitty, MD, MPH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 12, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Blastomycosis is a systemic pyogranulomatous infection that arises after inhalation of the conidia of the thermally dimorphic fungus <em>Blastomyces dermatitidis </em>or<em> Blastomyces gilchristii</em>. Most cases of blastomycosis have been reported in North America. (See <a href=\"topic.htm?path=mycology-pathogenesis-and-epidemiology-of-blastomycosis\" class=\"medical medical_review\">&quot;Mycology, pathogenesis, and epidemiology of blastomycosis&quot;</a>.) &#160;</p><p>The clinical manifestations of blastomycosis are varied and include asymptomatic infection, acute or chronic pneumonia, and extrapulmonary disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>]. Although blastomycosis has been reported to involve almost every organ, the lungs are the most common site of infection, followed by the skin, bones, and genitourinary system. Extrapulmonary disease results from hematogenous spread from a primary pulmonary infection. </p><p>The clinical manifestations and diagnosis of blastomycosis will be reviewed here. The mycology, pathogenesis, epidemiology, and treatment of blastomycosis are discussed separately. (See <a href=\"topic.htm?path=mycology-pathogenesis-and-epidemiology-of-blastomycosis\" class=\"medical medical_review\">&quot;Mycology, pathogenesis, and epidemiology of blastomycosis&quot;</a> and <a href=\"topic.htm?path=treatment-of-blastomycosis\" class=\"medical medical_review\">&quot;Treatment of blastomycosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">SITES OF INVOLVEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The lungs are the most common site of infection, followed by the skin, bones, and genitourinary tract [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/2,3\" class=\"abstract_t\">2,3</a>]. As an example, in a study of 326 patients with blastomycosis, the following distribution of organ involvement was observed [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/2\" class=\"abstract_t\">2</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary &ndash; 91 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin &ndash; 18 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bone &ndash; 4 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Genitourinary &ndash; 2 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central nervous system &ndash; 1 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other (laryngeal involvement, soft tissue, lymphatic, esophageal, joint, and tracheal involvement) &ndash; 3 percent</p><p/><p>In this study, 56 patients (17 percent) had multiorgan involvement, primarily involving either the lungs (95 percent) <span class=\"nowrap\">and/or</span> the skin (77 percent). Acute respiratory distress syndrome (ARDS) associated with blastomycosis has also been reported [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/3,4\" class=\"abstract_t\">3,4</a>]. In a series of 114 patients with blastomycosis from Indiana, ARDS was found in 17 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Studies performed prior to the availability of effective therapy indicated that approximately two-thirds of patients with blastomycosis had multiorgan involvement [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/5,6\" class=\"abstract_t\">5,6</a>] and that the disease was progressive with reported mortality rates of up to 90 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/7\" class=\"abstract_t\">7</a>]. However, most of these earlier studies were autopsy-based; thus, multiorgan disease was probably overrepresented. Later reports in Arkansas [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/8\" class=\"abstract_t\">8</a>], Wisconsin [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/9\" class=\"abstract_t\">9</a>], Mississippi [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/2\" class=\"abstract_t\">2</a>], and Manitoba, Canada [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/10\" class=\"abstract_t\">10</a>] described a lower frequency of extrapulmonary disease.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Both acute and chronic blastomycosis may mimic other diseases [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/11\" class=\"abstract_t\">11</a>]. This is due to the variability of the presentation of blastomycosis and its relative rarity. As an example, acute pulmonary blastomycosis may be initially diagnosed as community-acquired bacterial or viral pneumonia, whereas chronic pulmonary blastomycosis is often initially thought to be malignancy or tuberculosis. Skin lesions are frequently misdiagnosed as pyoderma gangrenosum or keratoacanthoma. Involvement of the larynx, brain, lymph nodes, skin, or other organs may be thought to be carcinoma.</p><p>Thus, a high index of suspicion and aggressive collection of samples for microbiology and histologic evaluation should be performed when the diagnosis is uncertain and patients live in or have traveled to areas endemic for blastomycosis.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">PULMONARY INVOLVEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The lungs are the usual portal of entry for blastomycosis. Patients may present with either acute or chronic pneumonia, although chronic pneumonia is more common. As defined in point source outbreaks, up to 50 percent of blastomycosis infections are asymptomatic [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/12-16\" class=\"abstract_t\">12-16</a>]. The incubation period from exposure until the onset of pulmonary symptoms is approximately three to six weeks [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/13\" class=\"abstract_t\">13</a>]. The incubation period from exposure to the onset of extrapulmonary symptoms is highly variable.</p><p>In a study that included 326 patients with blastomycosis, the following presenting symptoms were observed [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/2\" class=\"abstract_t\">2</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cough &ndash; 73 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fever &ndash; 54 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sputum production &ndash; 50 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chest pain &ndash; 41 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Shortness of breath &ndash; 38 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Weight loss of at least 5 percent &ndash; 37 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Night sweats &ndash; 31 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chills &ndash; 28 percent</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hemoptysis &ndash; 23 percent</p><p/><p>Other symptoms may include arthralgias, myalgias, and pleuritic chest pain.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Acute pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute infection is frequently unrecognized unless related to a cluster of cases. The signs and symptoms of acute pulmonary blastomycosis usually begin abruptly and may be indistinguishable from viral or bacterial pneumonia [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>Cough is initially nonproductive but often becomes productive of purulent sputum as the disease progresses. Patients may also experience fever, shortness of breath, weight loss, night sweats, <span class=\"nowrap\">and/or</span> other pulmonary or constitutional signs and symptoms. (See <a href=\"#H4\" class=\"local\">'Pulmonary involvement'</a> above.)</p><p>Chest radiography most commonly reveals alveolar infiltrates or a mass lesion, although miliary or reticulonodular patterns can also occur [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/17,18\" class=\"abstract_t\">17,18</a>]. Chest computed tomography (CT) scanning may show nodules, consolidation with or without cavitation, <span class=\"nowrap\">and/or</span> tree-in-bud opacities (<a href=\"image.htm?imageKey=ID%2F83713\" class=\"graphic graphic_diagnosticimage graphicRef83713 \">image 1</a> and <a href=\"image.htm?imageKey=ID%2F83714\" class=\"graphic graphic_picture graphicRef83714 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/19\" class=\"abstract_t\">19</a>]. Small pleural effusions are frequent. The lack of significant hilar adenopathy may be helpful in distinguishing blastomycosis from histoplasmosis, in which adenopathy is common. (See <a href=\"topic.htm?path=pathogenesis-and-clinical-features-of-pulmonary-histoplasmosis\" class=\"medical medical_review\">&quot;Pathogenesis and clinical features of pulmonary histoplasmosis&quot;</a>.)</p><p>Spontaneous resolution of acute pulmonary blastomycosis has been reported, but its frequency is unknown; patients with extrapulmonary manifestation often describe prior lung infection [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/16,20\" class=\"abstract_t\">16,20</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Chronic pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients diagnosed with blastomycosis may have a chronic pneumonia that is clinically similar to tuberculosis, other fungal infections (eg, histoplasmosis), or bronchogenic carcinoma [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>]. Diagnosis is often delayed for more than one month, even when patients seek medical attention within seven days of onset of illness, allowing patients to transition from acute to chronic pneumonia [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/2\" class=\"abstract_t\">2</a>]. Many of these patients received multiple rounds of antibiotics before the diagnosis was established. Additionally, some patients are initially asymptomatic but progress over time into the chronic form of blastomycosis. Symptoms may include low-grade fever, productive cough, hemoptysis, chest pain, <span class=\"nowrap\">and/or</span> weight loss.</p><p>The radiographic findings are varied. Alveolar infiltrates with or without cavitation, mass lesions, and fibronodular infiltrates are most common [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Infiltrates are more frequently reported in the upper lobes. Small pleural effusions and pleural thickening have been reported, but large pleural effusions are uncommon. Significant pleural involvement was associated with a poor outcome in one series [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/21\" class=\"abstract_t\">21</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Acute respiratory distress syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rarely, patients may present with diffuse pneumonitis associated with acute respiratory distress syndrome (ARDS) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1,22-24\" class=\"abstract_t\">1,22-24</a>]. In small case series, the mortality rate associated with ARDS due to blastomycosis was over 50 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/22,23\" class=\"abstract_t\">22,23</a>], and most deaths occurred during the first few days of treatment [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/23\" class=\"abstract_t\">23</a>]. </p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">EXTRAPULMONARY BLASTOMYCOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although extrapulmonary disease has been reported in over 50 percent of patients with chronic blastomycosis, most of these studies were autopsy based or were published prior to the availability of effective therapy [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/5,6,25-29\" class=\"abstract_t\">5,6,25-29</a>]. In contrast, more recent studies have documented multiorgan disease in approximately 20 percent of patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/2,8-10\" class=\"abstract_t\">2,8-10</a>]. Extrapulmonary disease is usually seen in conjunction with active pulmonary infection. (See <a href=\"#H2\" class=\"local\">'Sites of involvement'</a> above.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Skin</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin disease is the second most common manifestation of blastomycosis after pneumonia. The characteristic cutaneous finding is a verrucous lesion, with irregular borders (<a href=\"image.htm?imageKey=ID%2F83716\" class=\"graphic graphic_picture graphicRef83716 \">picture 2</a> and <a href=\"image.htm?imageKey=ID%2F83720\" class=\"graphic graphic_picture graphicRef83720 \">picture 3</a> and <a href=\"image.htm?imageKey=ID%2F83721\" class=\"graphic graphic_picture graphicRef83721 \">picture 4</a>). The color may range from gray to violet. This lesion may mimic squamous cell carcinoma. Microabscesses form at the periphery of verrucous lesions and biopsies taken from the margins usually reveal broad-based budding organisms on microscopy. Ulcerative lesions that bleed easily and have well-demarcated, heaped-up borders may also occur (<a href=\"image.htm?imageKey=ID%2F83717\" class=\"graphic graphic_picture graphicRef83717 \">picture 5</a> and <a href=\"image.htm?imageKey=ID%2F83718\" class=\"graphic graphic_picture graphicRef83718 \">picture 6</a>) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>]. </p><p>Subcutaneous nodules are cold abscesses that can be seen in patients with disseminated disease (<a href=\"image.htm?imageKey=ID%2F83719\" class=\"graphic graphic_picture graphicRef83719 \">picture 7</a>). Microscopic examination from these lesions reveals broad-based budding yeasts typical of <em>Blastomyces </em>(<a href=\"image.htm?imageKey=ID%2F63105\" class=\"graphic graphic_picture graphicRef63105 \">picture 8</a> and <a href=\"image.htm?imageKey=ID%2F66379\" class=\"graphic graphic_picture graphicRef66379 \">picture 9</a>).</p><p>Patients with cutaneous disease resulting from dissemination of lung disease have little or no regional lymphadenopathy. In contrast, lymphadenitis is a prominent finding in patients with inoculation blastomycosis due to a dog bite or inoculation of pathology staff by autopsy accident [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/30-32\" class=\"abstract_t\">30-32</a>]. There is a report of transmission of blastomycosis after a bite wound from a kinkajou, an exotic pet [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/33\" class=\"abstract_t\">33</a>]. However, the vast majority of cutaneous lesions are from hematogenous spread and not from direct inoculation. Patients with blastomycosis often have a history of pet dogs that died from blastomycosis. This suggests that both humans and their pets have become infected by aerosol inhalation from the environment. </p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Bone and joint</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Osteomyelitis is the next most common extrapulmonary manifestation of blastomycosis after cutaneous involvement, occurring in up to one-quarter of cases of patients with multiorgan disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/34\" class=\"abstract_t\">34</a>]. A retrospective study of 45 patients hospitalized with blastomycosis of bones or joints revealed that cutaneous disease was present in 33 (73 percent) and pulmonary disease in 29 (64 percent) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/35\" class=\"abstract_t\">35</a>]. This study is consistent with results from the University of Mississippi Medical Center, in which patients with isolated skin disease were at risk for infection in other nonpulmonary sites [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/2\" class=\"abstract_t\">2</a>]. Any bone may be involved, although the most common are the vertebrae, pelvis, and sacrum [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>Patients often present with soft tissue swelling or a chronic draining sinus tract adjacent to the focus of osteomyelitis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>]. There is usually little or no bone pain associated with osteomyelitis due to blastomycosis.</p><p>A well-circumscribed, osteolytic lesion is the most common radiographic finding. Vertebral disease can be radiographically similar to tuberculosis, with anterior involvement of the vertebral body and destruction of the disc interspace [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/36\" class=\"abstract_t\">36</a>]. Paravertebral abscesses are also commonly associated with vertebral blastomycosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/37\" class=\"abstract_t\">37</a>]. Biopsy of bone lesions caused by <em>Blastomyces dermatitidis</em> may reveal granuloma formation, suppuration, <span class=\"nowrap\">and/or</span> necrosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p>Arthritis due to blastomycosis usually results from direct extension from osteomyelitis and may be acute or chronic in its presentation.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Genitourinary system</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Extrapulmonary blastomycosis occurs most commonly in men; genitourinary system involvement presents as prostatitis and epididymoorchitis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/38,39\" class=\"abstract_t\">38,39</a>]. Some patients have asymptomatic pyuria. Urine cultures are more likely to be positive if specimens are obtained after prostatic massage and the sediment is cultured after centrifugation.</p><p>Rare cases of tuboovarian abscess or endometritis have been reported in women [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/40\" class=\"abstract_t\">40</a>]. In one case report, a woman acquired blastomycosis by sexual transmission from a man who had disseminated disease [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Central nervous system</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Blastomycosis of the central nervous system (CNS) is uncommon in immunocompetent hosts, and has been reported in fewer than 5 percent of cases. CNS infection may present as meningitis, epidural abscess, or intracranial abscesses, particularly in the cerebellum [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/41\" class=\"abstract_t\">41</a>]. CNS involvement may occur in immunocompromised patients, especially those with AIDS [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/42\" class=\"abstract_t\">42</a>]. In a retrospective study of HIV-infected patients with blastomycosis, 6 of 15 had CNS involvement, usually manifested as single or multiple brain abscesses [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/42\" class=\"abstract_t\">42</a>]. In one review, 10 of 22 patients with CNS blastomycosis were not considered to be immunosuppressed [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/41\" class=\"abstract_t\">41</a>]. Of note, 17 of the 22 patients had evidence of blastomycosis in other organs as well. </p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Other sites</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>B. dermatitidis</em> has been reported to involve almost every organ, including lymph nodes, liver, spleen, breast, adrenal gland, thyroid, and eye [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>]. Blastomycosis has also been reported in the mucosa of the nose, mouth, and larynx.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">SPECIAL POPULATIONS</span></p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Children</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An estimated 10 percent of patients reported with blastomycosis are children [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/10,12,43\" class=\"abstract_t\">10,12,43</a>]. The clinical spectrum in pediatric disease is similar to that in adults.</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Pregnancy and perinatal transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Blastomycosis has been reported, albeit infrequently, during pregnancy. Pregnant women are more likely to have disseminated disease than nonpregnant individuals; this may be related to the depressed cellular immunity associated with pregnancy [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/44\" class=\"abstract_t\">44</a>].</p><p>Perinatal transmission has been documented. Infection may result from aspiration of infected vaginal secretions during childbirth, an ascending vaginal infection associated with premature rupture of the membranes, or transplacental infection.</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h2\">Immunocompromised hosts</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Blastomyces</em> can behave as an opportunistic pathogen, especially in patients with advanced AIDS, transplant recipients, those who are prescribed TNF-alpha inhibitors, and other immunocompromised patients [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1,11,45,46\" class=\"abstract_t\">1,11,45,46</a>]. Pulmonary disease tends to be more severe in immunocompromised hosts, including findings of diffuse pulmonary infiltrates, large pleural effusions, <span class=\"nowrap\">and/or</span> respiratory failure. Additionally, disseminated disease is more common in immunocompromised patients, the clinical course is more aggressive, and there is a higher mortality rate (up to 40 percent) than in immunocompetent patients.</p><p>Frequent relapses have been reported in patients with AIDS and in patients who remain on immunosuppressive therapy. This is discussed in detail separately. (See <a href=\"topic.htm?path=treatment-of-blastomycosis#H20\" class=\"medical medical_review\">&quot;Treatment of blastomycosis&quot;, section on 'Immunocompromised hosts'</a>.)</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Definitive diagnosis requires growth of the organism from a clinical specimen [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>]. Unlike <em>Candida</em> and <em>Aspergillus </em>spp, colonization or contamination with <em>Blastomyces</em> does not occur, which means that visualizing the organism on histology or obtaining a positive culture confirms the diagnosis of blastomycosis. Presumptive diagnosis of blastomycosis may be made by visualization of the characteristic yeast form in clinical specimens, such as sputum, tissue, or purulent material. In the appropriate clinical situation, visualization may justify beginning empirical antifungal therapy. Serology is not useful for the diagnosis of blastomycosis.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Culture</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Identification of <em>Blastomyces</em> by culture depends upon growth of the organism in the mycelial phase and conversion of the mycelial phase to the yeast phase, or use of a commercially available DNA probe that allows the rapid identification of a mold that has grown in culture as being <em>B. dermatitidis</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/47\" class=\"abstract_t\">47</a>]. The mold form of the organism is not difficult to culture from most clinical specimens using Sabouraud dextrose agar without cycloheximide at 25 to 30&ordm;C; it typically grows within one to four weeks [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"abstract_t\">1</a>]. The mycelial phase produces spherical, oval, or pyriform conidia from aerial hyphae. At 37&ordm;C, B. dermatitidis colonies are wrinkled, pasty, and moist. The yeast cell, whether in vitro or in tissue, is thick walled and spherical, producing single buds with a broad base of attachment between the bud and parent cell (<a href=\"image.htm?imageKey=ID%2F66379\" class=\"graphic graphic_picture graphicRef66379 \">picture 9</a> and <a href=\"image.htm?imageKey=ID%2F63105\" class=\"graphic graphic_picture graphicRef63105 \">picture 8</a>).</p><p>In adult patients with pulmonary blastomycosis, sputum culture has a high yield (75 percent per single sample, 86 percent per patient) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/48\" class=\"abstract_t\">48</a>]. Specimens obtained for culture by bronchoscopy yield a positive diagnosis in 92 percent of patients. Specimens are frequently contaminated with bacteria that inhibit fungal growth and should thus also be cultured on medium containing <a href=\"topic.htm?path=chloramphenicol-drug-information\" class=\"drug drug_general\">chloramphenicol</a>.</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Direct examination of clinical specimens</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although wet preparations have a relatively low diagnostic yield (36 percent for a single specimen and 46 percent for multiple specimens) [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/48\" class=\"abstract_t\">48</a>], the simplicity and low cost of the procedure, as well as its potential for rapid diagnosis, justify a wet preparation on all clinical specimens.</p><p>Fresh wet preparations of sputum, pleural fluid, bronchoalveolar lavage fluid, cerebrospinal fluid, urine, purulent material, skin scrapings, or tissue impression smears may be examined directly with calcofluor white, 10 percent potassium hydroxide (KOH), or both. KOH has been recommended to aid in finding yeast and fungal elements, but most laboratories have supplanted this with calcofluor white, which causes the yeast cell wall to fluoresce. Calcofluor white staining requires use of a fluorescence microscope but is easy, rapid, and particularly useful when organisms are sparse.</p><p>It is useful to concentrate clinical specimens, such as sputum, urine, pleural fluid, and cerebrospinal fluid by centrifugation. It is also helpful to digest sputum samples with trypsin and smear the centrifuged sediment.</p><p>When visualized, the yeast cells are easily differentiated from others on the basis of their size (8 to 15 microns in diameter), refractile cell wall, and single, broad-based buds (<a href=\"image.htm?imageKey=ID%2F66379\" class=\"graphic graphic_picture graphicRef66379 \">picture 9</a> and <a href=\"image.htm?imageKey=ID%2F63105\" class=\"graphic graphic_picture graphicRef63105 \">picture 8</a> and <a href=\"image.htm?imageKey=ID%2F62300\" class=\"graphic graphic_picture graphicRef62300 \">picture 10</a>). Occasionally, the endospores of <em>Coccidioides</em> species may resemble single yeast cells, but the presence of broad-based budding yeasts can be used to distinguish <em>Blastomyces</em>. <em>Paracoccidioides brasiliensis</em>, rarely seen in the United States, is distinguished from <em>Blastomyces </em>by the presence of multiple, narrow-based buds arranged around the periphery of the mother cell. <em>Blastomyces </em>may sometimes be as small as <em>Cryptococcus neoformans</em>, although the capsule and narrow-based bud of the latter aid in differentiation. (See <a href=\"topic.htm?path=coccidioidomycosis-laboratory-diagnosis-and-screening\" class=\"medical medical_review\">&quot;Coccidioidomycosis: Laboratory diagnosis and screening&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-paracoccidioidomycosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of chronic paracoccidioidomycosis&quot;</a> and <a href=\"topic.htm?path=microbiology-and-epidemiology-of-cryptococcus-neoformans-infection\" class=\"medical medical_review\">&quot;Microbiology and epidemiology of Cryptococcus neoformans infection&quot;</a>.)</p><p>In patients who are not producing sputum or in whom lung imaging indicates the possibility of malignancy, bronchoscopy is particularly useful [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/48\" class=\"abstract_t\">48</a>]. In addition to fungal staining and culture, bronchial washings, bronchoalveolar lavage fluid, and post-bronchoscopy sputum samples should be evaluated using cytology because the organism is often visualized on Papanicolaou preparations [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/49\" class=\"abstract_t\">49</a>].</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h2\">Histopathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A pyogranulomatous tissue response is frequently seen in blastomycosis and should signal the possibility of this fungus. Yeast forms can be difficult to visualize with routine hematoxylin and eosin stains, and special stains, such as the methenamine silver stain or the periodic acid-Schiff (PAS) stain, are particularly useful for examining tissue for the presence of fungal elements (<a href=\"image.htm?imageKey=ID%2F83714\" class=\"graphic graphic_picture graphicRef83714 \">picture 1</a>). </p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h2\">Serologic testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Serologic testing is not useful for the diagnosis of blastomycosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/50\" class=\"abstract_t\">50</a>], owing to the high degree of cross-reactivity shared by the endemic mycoses, most notably <em>Histoplasma capsulatum</em>. Immunodiffusion assays that measure antibody to <em>Blastomyces dermatitidis</em> A antigen are relatively specific, but sensitivity is only 28 to 64 percent [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/51,52\" class=\"abstract_t\">51,52</a>]. Complement fixation tests perform even less well, with sensitivities of 9 to 43 percent and poor specificity [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/51,52\" class=\"abstract_t\">51,52</a>]. Enzyme immunoassays employing A antigen are the least reliable, with greater sensitivity but lower specificity compared with other methods [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/51-54\" class=\"abstract_t\">51-54</a>]. Serologic studies using yeast phase lysates from multiple sources of <em>B. dermatitidis</em> have been explored for IgM and IgG antibody detection in an effort to improve immunodiagnostic testing for blastomycosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/55,56\" class=\"abstract_t\">55,56</a>]. Although these tests are promising, they have not been validated using human specimens. A study of patients with blastomycosis reported 88 percent sensitivity of an enzyme immunoassay employing the BAD1 surface protein of <em>B. dermatitidis</em> [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/57\" class=\"abstract_t\">57</a>], but the test is not yet commercially available.</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h2\">Nucleic acid detection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Molecular identification of <em>B. dermatitidis</em> has been accomplished by a variety of techniques, including polymerase chain reaction (PCR) assays for ribosomal genes [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/58,59\" class=\"abstract_t\">58,59</a>], the ITS-region [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/58\" class=\"abstract_t\">58</a>], repetitive sequences [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/59\" class=\"abstract_t\">59</a>], and species- or genus-specific genes [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/60,61\" class=\"abstract_t\">60,61</a>]. In addition, real-time PCR assays that can identify <em>B. dermatitidis</em> in culture specimens, in various clinical specimens (eg, bronchial washings, bronchoalveolar fluid, pleural fluid, sputum, blood), and in paraffin-embedded tissue have been developed [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/62,63\" class=\"abstract_t\">62,63</a>]. A number of case reports have used detection of <em>B. dermatitidis</em> DNA in histology tissue blocks to confirm the diagnosis of blastomycosis as this technique has become increasingly available [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/64,65\" class=\"abstract_t\">64,65</a>]. However, PCR techniques are labor intensive, and although promising, their utility has not been confirmed in large prospective studies. </p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h2\">Antigen detection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The detection of fungal antigens in serum and urine has proven useful in the diagnosis and treatment of patients with certain invasive mycoses, such as histoplasmosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/50\" class=\"abstract_t\">50</a>]. An antigen detection assay for blastomycosis is currently available for clinical use [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/66\" class=\"abstract_t\">66</a>]. The sensitivity of this assay is 89 percent in disseminated blastomycosis and 93 percent overall. Sensitivity is higher in urine than in serum. However, specificity is modest, 79 percent overall, and due to cross-reactive antigens present in specimens obtained from patients with histoplasmosis, paracoccidioidomycosis, and penicilliosis [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/67\" class=\"abstract_t\">67</a>]. Cross-reactivity was less than 5 percent for patients with aspergillosis or cryptococcosis and less than 2 percent in healthy adults [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/50\" class=\"abstract_t\">50</a>].</p><p>Antigen levels appear to decline with successful treatment and increase with recurrence of illness [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/68,69\" class=\"abstract_t\">68,69</a>]. In a more recent review, 23 of 27 patients (85 percent) with recently diagnosed blastomycosis had antigenuria detected while none of 50 control subjects had <em>B. dermatitidis</em> antigenuria [<a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/70\" class=\"abstract_t\">70</a>]. Despite the benefits of antigen detection, its utility is limited given the ease of diagnosis by conventional methods and the modest specificity provided by these assays.</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The clinical manifestations of blastomycosis are varied and include asymptomatic infection, acute or chronic pneumonia, and extrapulmonary disease. Although blastomycosis has been reported to involve almost every organ, the lungs are the most common site. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Both acute and chronic blastomycosis often mimic other diseases. Acute pulmonary blastomycosis may be initially diagnosed as community-acquired bacterial or viral pneumonia, whereas chronic pulmonary blastomycosis is most often thought to be malignancy or tuberculosis. Acute infection is frequently unrecognized unless related to a cluster of cases. (See <a href=\"#H3\" class=\"local\">'Differential diagnosis'</a> above and <a href=\"#H5\" class=\"local\">'Acute pneumonia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Most patients present with chronic pneumonia. Skin disease is the second most common manifestation and is characterized by verrucous lesions (<a href=\"image.htm?imageKey=ID%2F83716\" class=\"graphic graphic_picture graphicRef83716 \">picture 2</a> and <a href=\"image.htm?imageKey=ID%2F83720\" class=\"graphic graphic_picture graphicRef83720 \">picture 3</a> and <a href=\"image.htm?imageKey=ID%2F83721\" class=\"graphic graphic_picture graphicRef83721 \">picture 4</a>), ulcerative lesions (<a href=\"image.htm?imageKey=ID%2F83717\" class=\"graphic graphic_picture graphicRef83717 \">picture 5</a> and <a href=\"image.htm?imageKey=ID%2F83718\" class=\"graphic graphic_picture graphicRef83718 \">picture 6</a>), or subcutaneous nodules (<a href=\"image.htm?imageKey=ID%2F83719\" class=\"graphic graphic_picture graphicRef83719 \">picture 7</a>). Osteomyelitis is the next most common extrapulmonary manifestation. (See <a href=\"#H6\" class=\"local\">'Chronic pneumonia'</a> above and <a href=\"#H9\" class=\"local\">'Skin'</a> above and <a href=\"#H10\" class=\"local\">'Bone and joint'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary disease tends to be more severe in immunocompromised hosts. There is a higher mortality rate (up to 40 percent) than in immunocompetent patients. (See <a href=\"#H17\" class=\"local\">'Immunocompromised hosts'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Definitive diagnosis requires culturing the organism from clinical specimens, but a presumptive diagnosis of blastomycosis may be made by visualization of the characteristic yeast form in clinical specimens such as sputum, tissue, or purulent material. (See <a href=\"#H18\" class=\"local\">'Diagnosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/1\" class=\"nounderline abstract_t\">Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 2010; 23:367.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/2\" class=\"nounderline abstract_t\">Chapman SW, Lin AC, Hendricks KA, et al. Endemic blastomycosis in Mississippi: epidemiological and clinical studies. Semin Respir Infect 1997; 12:219.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/3\" class=\"nounderline abstract_t\">Azar MM, Assi R, Relich RF, et al. Blastomycosis in Indiana: Clinical and Epidemiologic Patterns of Disease Gleaned from a Multicenter Retrospective Study. Chest 2015; 148:1276.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/4\" class=\"nounderline abstract_t\">Mansour MK, Ackman JB, Branda JA, Kradin RL. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 32-2015. A 57-Year-Old Man with Severe Pneumonia and Hypoxemic Respiratory Failure. N Engl J Med 2015; 373:1554.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/5\" class=\"nounderline abstract_t\">KAPLAN W, CLIFFORD MK. BLASTOMYCOSIS. I. A REVIEW OF 198 COLLECTED CASES IN VETERANS ADMINISTRATION HOSPITALS. Am Rev Respir Dis 1964; 89:659.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/6\" class=\"nounderline abstract_t\">Witorsch P, Utz JP. North American blastomycosis: a study of 40 patients. Medicine (Baltimore) 1968; 47:169.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/7\" class=\"nounderline abstract_t\">Martin, DS, Smith, DT. Blastomycosis I: A review of the literature. Am Rev Tuberc 1939; 39:275.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/8\" class=\"nounderline abstract_t\">Bradsher RW, Rice DC, Abernathy RS. Ketoconazole therapy for endemic blastomycosis. Ann Intern Med 1985; 103:872.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/9\" class=\"nounderline abstract_t\">Baumgardner DJ, Buggy BP, Mattson BJ, et al. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin Infect Dis 1992; 15:629.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/10\" class=\"nounderline abstract_t\">Crampton TL, Light RB, Berg GM, et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin Infect Dis 2002; 34:1310.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/11\" class=\"nounderline abstract_t\">Bradsher RW, Chapman SW, Pappas PG. Blastomycosis. Infect Dis Clin North Am 2003; 17:21.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/12\" class=\"nounderline abstract_t\">Klein BS, Vergeront JM, DiSalvo AF, et al. Two outbreaks of blastomycosis along rivers in Wisconsin. Isolation of Blastomyces dermatitidis from riverbank soil and evidence of its transmission along waterways. Am Rev Respir Dis 1987; 136:1333.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/13\" class=\"nounderline abstract_t\">Klein BS, Vergeront JM, Davis JP. Epidemiologic aspects of blastomycosis, the enigmatic systemic mycosis. Semin Respir Infect 1986; 1:29.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/14\" class=\"nounderline abstract_t\">Proctor ME, Klein BS, Jones JM, Davis JP. Cluster of pulmonary blastomycosis in a rural community: evidence for multiple high-risk environmental foci following a sustained period of diminished precipitation. Mycopathologia 2002; 153:113.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/15\" class=\"nounderline abstract_t\">Klein BS, Vergeront JM, Weeks RJ, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986; 314:529.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/16\" class=\"nounderline abstract_t\">Vaaler AK, Bradsher RW, Davies SF. Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin. Am J Med 1990; 89:470.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/17\" class=\"nounderline abstract_t\">Sheflin JR, Campbell JA, Thompson GP. Pulmonary blastomycosis: findings on chest radiographs in 63 patients. AJR Am J Roentgenol 1990; 154:1177.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/18\" class=\"nounderline abstract_t\">Brown LR, Swensen SJ, Van Scoy RE, et al. Roentgenologic features of pulmonary blastomycosis. Mayo Clin Proc 1991; 66:29.</a></li><li class=\"breakAll\">Fungal and parasitic infection. In: Imaging of Pulmonary Infections, Muller NL, Franquet T, Soo Lee K (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. p.115.</li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/20\" class=\"nounderline abstract_t\">Sarosi GA, Davies SF, Phillips JR. Self-limited blastomycosis: a report of 39 cases. Semin Respir Infect 1986; 1:40.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/21\" class=\"nounderline abstract_t\">Kinasewitz GT, Penn RL, George RB. The spectrum and significance of pleural disease in blastomycosis. Chest 1984; 86:580.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/22\" class=\"nounderline abstract_t\">Meyer KC, McManus EJ, Maki DG. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome. N Engl J Med 1993; 329:1231.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/23\" class=\"nounderline abstract_t\">Lemos LB, Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol 2001; 5:1.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/24\" class=\"nounderline abstract_t\">Lahm T, Neese S, Thornburg AT, et al. Corticosteroids for blastomycosis-induced ARDS: a report of two patients and review of the literature. Chest 2008; 133:1478.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/25\" class=\"nounderline abstract_t\">CHERNISS EI, WAISBREN BA. North American blastomycosis: a clinical study of 40 cases. Ann Intern Med 1956; 44:105.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/26\" class=\"nounderline abstract_t\">ABERNATHY RS. Clinical manifestations of pulmonary blastomycosis. Ann Intern Med 1959; 51:707.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/27\" class=\"nounderline abstract_t\">Lockwood WR, Allison F Jr, Batson BE, Busey JF. The treatment of North American blastomycosis. Ten years' experience. Am Rev Respir Dis 1969; 100:314.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/28\" class=\"nounderline abstract_t\">Duttera MJ Jr, Osterhout S. North American blastomycosis: a survey of 63 cases. South Med J 1969; 62:295.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/29\" class=\"nounderline abstract_t\">Busey JF. Blastomycosis. 3. A comparative study of 2-hydroxystilbamidine and amphotericin B therapy. Am Rev Respir Dis 1972; 105:812.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/30\" class=\"nounderline abstract_t\">Gnann JW Jr, Bressler GS, Bodet CA 3rd, Avent CK. Human blastomycosis after a dog bite. Ann Intern Med 1983; 98:48.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/31\" class=\"nounderline abstract_t\">Larson DM, Eckman MR, Alber RL, Goldschmidt VG. Primary cutaneous (inoculation) blastomycosis: an occupational hazard to pathologists. Am J Clin Pathol 1983; 79:253.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/32\" class=\"nounderline abstract_t\">Gray NA, Baddour LM. Cutaneous inoculation blastomycosis. Clin Infect Dis 2002; 34:E44.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/33\" class=\"nounderline abstract_t\">Harris JR, Blaney DD, Lindsley MD, et al. Blastomycosis in man after kinkajou bite. Emerg Infect Dis 2011; 17:268.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/34\" class=\"nounderline abstract_t\">Moore RM, Green NE. Blastomycosis of bone. A report of six cases. J Bone Joint Surg Am 1982; 64:1097.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/35\" class=\"nounderline abstract_t\">Oppenheimer M, Embil JM, Black B, et al. Blastomycosis of bones and joints. South Med J 2007; 100:570.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/36\" class=\"nounderline abstract_t\">G&uuml;ler N, Palanduz A, Ones U, et al. Progressive vertebral blastomycosis mimicking tuberculosis. Pediatr Infect Dis J 1995; 14:816.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/37\" class=\"nounderline abstract_t\">Saccente M, Abernathy RS, Pappas PG, et al. Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature. Clin Infect Dis 1998; 26:413.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/38\" class=\"nounderline abstract_t\">Inoshita T, Youngberg GA, Boelen LJ, Langston J. Blastomycosis presenting with prostatic involvement: report of 2 cases and review of the literature. J Urol 1983; 130:160.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/39\" class=\"nounderline abstract_t\">Seo R, Oyasu R, Schaeffer A. Blastomycosis of the epididymis and prostate. Urology 1997; 50:980.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/40\" class=\"nounderline abstract_t\">Eickenberg H-U, Amin M, Lich R Jr. Blastomycosis of the genitourinary tract. J Urol 1975; 113:650.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/41\" class=\"nounderline abstract_t\">Bariola JR, Perry P, Pappas PG, et al. Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era. Clin Infect Dis 2010; 50:797.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/42\" class=\"nounderline abstract_t\">Pappas PG, Pottage JC, Powderly WG, et al. Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1992; 116:847.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/43\" class=\"nounderline abstract_t\">Dworkin MS, Duckro AN, Proia L, et al. The epidemiology of blastomycosis in Illinois and factors associated with death. Clin Infect Dis 2005; 41:e107.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/44\" class=\"nounderline abstract_t\">Lemos LB, Soofi M, Amir E. Blastomycosis and pregnancy. Ann Diagn Pathol 2002; 6:211.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/45\" class=\"nounderline abstract_t\">Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore) 1993; 72:311.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/46\" class=\"nounderline abstract_t\">Serody JS, Mill MR, Detterbeck FC, et al. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis 1993; 16:54.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/47\" class=\"nounderline abstract_t\">Stockman L, Clark KA, Hunt JM, Roberts GD. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol 1993; 31:845.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/48\" class=\"nounderline abstract_t\">Martynowicz MA, Prakash UB. Pulmonary blastomycosis: an appraisal of diagnostic techniques. Chest 2002; 121:768.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/49\" class=\"nounderline abstract_t\">Lemos LB, Baliga M, Taylor BD, et al. Bronchoalveolar lavage for diagnosis of fungal disease. Five years' experience in a southern United States rural area with many blastomycosis cases. Acta Cytol 1995; 39:1101.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/50\" class=\"nounderline abstract_t\">Wheat LJ. Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host. Transpl Infect Dis 2006; 8:128.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/51\" class=\"nounderline abstract_t\">Klein BS, Kuritsky JN, Chappell WA, et al. Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis. Am Rev Respir Dis 1986; 133:144.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/52\" class=\"nounderline abstract_t\">Klein BS, Vergeront JM, Kaufman L, et al. Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis 1987; 155:262.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/53\" class=\"nounderline abstract_t\">Bradsher RW, Pappas PG. Detection of specific antibodies in human blastomycosis by enzyme immunoassay. South Med J 1995; 88:1256.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/54\" class=\"nounderline abstract_t\">Sekhon AS, Kaufman L, Kobayashi GS, et al. The value of the Premier enzyme immunoassay for diagnosing Blastomyces dermatitidis infections. J Med Vet Mycol 1995; 33:123.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/55\" class=\"nounderline abstract_t\">Abuodeh RO, Chester EM, Scalarone GM. Comparative serological evaluation of 10 Blastomyces dermatitidis yeast phase lysate antigens from different sources. Mycoses 2004; 47:143.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/56\" class=\"nounderline abstract_t\">Sestero CM, Scalarone GM. Detection of IgG and IgM in sera from canines with blastomycosis using eight blastomyces dermatitidis yeast phase lysate antigens. Mycopathologia 2006; 162:33.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/57\" class=\"nounderline abstract_t\">Richer SM, Smedema ML, Durkin MM, et al. Development of a highly sensitive and specific blastomycosis antibody enzyme immunoassay using Blastomyces dermatitidis surface protein BAD-1. Clin Vaccine Immunol 2014; 21:143.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/58\" class=\"nounderline abstract_t\">Sandhu GS, Kline BC, Stockman L, Roberts GD. Molecular probes for diagnosis of fungal infections. J Clin Microbiol 1995; 33:2913.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/59\" class=\"nounderline abstract_t\">Bialek R, Cirera AC, Herrmann T, et al. Nested PCR assays for detection of Blastomyces dermatitidis DNA in paraffin-embedded canine tissue. J Clin Microbiol 2003; 41:205.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/60\" class=\"nounderline abstract_t\">Hayden RT, Qian X, Roberts GD, Lloyd RV. In situ hybridization for the identification of yeastlike organisms in tissue section. Diagn Mol Pathol 2001; 10:15.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/61\" class=\"nounderline abstract_t\">Abbott JJ, Hamacher KL, Ahmed I. In situ hybridization in cutaneous deep fungal infections: a valuable diagnostic adjunct to fungal morphology and tissue cultures. J Cutan Pathol 2006; 33:426.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/62\" class=\"nounderline abstract_t\">Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol 2012; 50:1783.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/63\" class=\"nounderline abstract_t\">Babady NE, Buckwalter SP, Hall L, et al. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol 2011; 49:3204.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/64\" class=\"nounderline abstract_t\">MacFadden DR, Gold WL, Richardson SE, Bunce PE. A breast mass in a 56-year-old man. CMAJ 2011; 183:1875.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/65\" class=\"nounderline abstract_t\">Vindenes T, Gardiner BJ, Nierenberg N, Volpe G. Pneumonia, septic arthritis, and brain abscesses in a construction worker. Clin Infect Dis 2015; 60:1722.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/66\" class=\"nounderline abstract_t\">Durkin M, Witt J, Lemonte A, et al. Antigen assay with the potential to aid in diagnosis of blastomycosis. J Clin Microbiol 2004; 42:4873.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/67\" class=\"nounderline abstract_t\">Wheat J, Wheat H, Connolly P, et al. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis 1997; 24:1169.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/68\" class=\"nounderline abstract_t\">Tarr M, Marcinak J, Mongkolrattanothai K, et al. Blastomyces antigen detection for monitoring progression of blastomycosis in a pregnant adolescent. Infect Dis Obstet Gynecol 2007; 2007:89059.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/69\" class=\"nounderline abstract_t\">Mongkolrattanothai K, Peev M, Wheat LJ, Marcinak J. Urine antigen detection of blastomycosis in pediatric patients. Pediatr Infect Dis J 2006; 25:1076.</a></li><li><a href=\"https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-blastomycosis/abstract/70\" class=\"nounderline abstract_t\">Bariola JR, Hage CA, Durkin M, et al. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis. Diagn Microbiol Infect Dis 2011; 69:187.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 2437 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H25\"><span>SUMMARY</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">SITES OF INVOLVEMENT</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">PULMONARY INVOLVEMENT</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Acute pneumonia</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Chronic pneumonia</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Acute respiratory distress syndrome</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">EXTRAPULMONARY BLASTOMYCOSIS</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Skin</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Bone and joint</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Genitourinary system</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Central nervous system</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Other sites</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">SPECIAL POPULATIONS</a><ul><li><a href=\"#H15\" id=\"outline-link-H15\">Children</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">Pregnancy and perinatal transmission</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">Immunocompromised hosts</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">DIAGNOSIS</a><ul><li><a href=\"#H19\" id=\"outline-link-H19\">Culture</a></li><li><a href=\"#H20\" id=\"outline-link-H20\">Direct examination of clinical specimens</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">Histopathology</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">Serologic testing</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">Nucleic acid detection</a></li><li><a href=\"#H24\" id=\"outline-link-H24\">Antigen detection</a></li></ul></li><li><a href=\"#H25\" id=\"outline-link-H25\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/2437|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/83713\" class=\"graphic graphic_diagnosticimage\">- Blastomycosis chest CT</a></li></ul></li><li><div id=\"ID/2437|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/83714\" class=\"graphic graphic_picture\">- Blastomycosis chest CT and histopathology</a></li><li><a href=\"image.htm?imageKey=ID/83716\" class=\"graphic graphic_picture\">- Verrucous skin lesion in blastomycosis</a></li><li><a href=\"image.htm?imageKey=ID/83720\" class=\"graphic graphic_picture\">- Verrucous skin lesions in blastomycosis</a></li><li><a href=\"image.htm?imageKey=ID/83721\" class=\"graphic graphic_picture\">- Skin lesion in blastomycosis</a></li><li><a href=\"image.htm?imageKey=ID/83717\" class=\"graphic graphic_picture\">- Ulcerative breast lesion in blastomycosis</a></li><li><a href=\"image.htm?imageKey=ID/83718\" class=\"graphic graphic_picture\">- Ulcerative lesion in blastomycosis</a></li><li><a href=\"image.htm?imageKey=ID/83719\" class=\"graphic graphic_picture\">- Subcutaneous nodules in blastomycosis</a></li><li><a href=\"image.htm?imageKey=ID/63105\" class=\"graphic graphic_picture\">- Budding of yeast phase</a></li><li><a href=\"image.htm?imageKey=ID/66379\" class=\"graphic graphic_picture\">- B dermatitidis wet mount</a></li><li><a href=\"image.htm?imageKey=ID/62300\" class=\"graphic graphic_picture\">- Refractile cell wall in yeast</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-paracoccidioidomycosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of chronic paracoccidioidomycosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=coccidioidomycosis-laboratory-diagnosis-and-screening\" class=\"medical medical_review\">Coccidioidomycosis: Laboratory diagnosis and screening</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=microbiology-and-epidemiology-of-cryptococcus-neoformans-infection\" class=\"medical medical_review\">Microbiology and epidemiology of Cryptococcus neoformans infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mycology-pathogenesis-and-epidemiology-of-blastomycosis\" class=\"medical medical_review\">Mycology, pathogenesis, and epidemiology of blastomycosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathogenesis-and-clinical-features-of-pulmonary-histoplasmosis\" class=\"medical medical_review\">Pathogenesis and clinical features of pulmonary histoplasmosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-blastomycosis\" class=\"medical medical_review\">Treatment of blastomycosis</a></li></ul></div></div>","javascript":null}